0 Commentarii
0 Distribuiri
1040 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
- Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
- Insights into the Niemann-Pick Disease Drug Type C Treatment MarketIn the domain of rare genetic disorders, the Niemann-Pick Disease Drug Type C Treatment Market holds a critical position, offering hope to individuals and families affected by this debilitating condition. Understanding key takeaways, opportunities, market drivers, and potential global expansion avenues is essential for stakeholders invested in advancing treatments for Niemann-Pick Disease Type...0 Commentarii 0 Distribuiri 593 Views 0 previzualizare
- Niemann-Pick Disease Drug Type C Treatment Market to Witness High Growth Due to Growing Prevalence of NPDTC DiseaseNiemann-Pick disease type C (NPDTC) is a rare, progressive genetic disorder that affects several organs in the body. It impairs the body's ability to metabolize cholesterol and other lipids which builds up in the brain, liver, spleen, lungs and other tissues. The most common initial symptoms are vertical supranuclear gaze palsy, dystonia, and dysarthria which further lead to neurological...0 Commentarii 0 Distribuiri 1039 Views 0 previzualizare
- Niemann-Pick Disease Drug Type C Treatment Market Witnesses High Growth due to Advancements in Therapeutic DrugsNiemann-Pick disease Type C is a rare genetic lysosomal storage disorder that prevents cholesterol and other lipids from being processed and utilized properly by cells in the body. If left untreated, it can lead to progressive neurological dysfunction and early death. Currently, cerliponase alfa injection ( trade name Brineura) and miglustat (Zavesca) are the only approved treatments for this...0 Commentarii 0 Distribuiri 862 Views 0 previzualizare
- Niemann-Pick Disease Type C Therapeutics Market Share, Overview, Competitive Analysis and Forecast 2031The Niemann-Pick Disease Type C Therapeutics Market in 2023 is US$ 55.48 million, and is expected to reach US$ 276.27 million by 2031 at a CAGR of 22.20%. FutureWise Research published a report that analyzes Niemann-Pick Disease Type C Therapeutics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary...0 Commentarii 0 Distribuiri 956 Views 0 previzualizare
- The Rising "Niemann-Pick Disease Drug Type C Treatment Market" is driven by Growing AwarenessThe Niemann-Pick disease drug type C treatment market involves drugs that are used for the treatment of Niemann-Pick disease type C. Niemann-Pick disease type C is a rare inherited lysosomal storage disorder that causes fatty substances and cholesterol to build up in various tissues of the body, including the brain and the liver. Drugs used in the treatment of Niemann-Pick disease type C...0 Commentarii 0 Distribuiri 612 Views 0 previzualizare